Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
BioStem Technologies, a Nasdaq-listed regenerative medicine company, announced a private placement of 735,296 shares and warrants priced at-the-market, expected to raise approximately $3 million before fees. The funds will be used for working capital and general corporate purposes. Warrants issued could provide additional proceeds if exercised, tho…
Verrica Pharmaceuticals announced they will present new analysis from Phase 3 trials indicating their FDA-approved drug YCANTH (VP-102) clears molluscum contagiosum lesions approximately four times faster than vehicle, regardless of disease duration. Additional data on investigational drug VP-315 for skin cancer will also be showcased. The clinical…
Cycurion, Inc. announced its largest contract award to date, a $54.6 million 10-year engagement supporting the modernization of a major state Health and Human Services system. The company also completed the acquisition of Digital Ally's Video Solutions business, expanding its public safety portfolio and recurring revenue base. CEO L. Kevin Kelly em…
Integer Holdings Corporation announced early termination of the Hart-Scott-Rodino waiting period necessary for the acquisition by KKR affiliates at $127 per share, valuing the deal at approximately $5.7 billion. The transaction awaits stockholder approval and other customary closing conditions, with completion expected by the end of 2026.
California BanCorp, the holding company for California Bank of Commerce, announced it will open a new commercial loan production office in downtown San Francisco to strengthen its presence and service offerings in the Bay Area, reflecting its commitment to strategic growth in Northern California.
Tokyo Lifestyle Co., Ltd. announced a year-end cash dividend of JPY 1.890 per share for the fiscal year ending March 31, 2026, highlighting its focus on shareholder returns while balancing capital allocation and long-term growth. The company intends to continue prudent capital management to support sustainable business growth and value creation for…
Banzai International, Inc. (Parabolic) has executed initiatives following its ConnectAndSell acquisition that are expected to yield approximately $9.3 million in annualized cost savings. These savings come from workforce reductions, minimized third-party contractor use, and the implementation of a new business unit operating model aimed at improvin…
Celcuity Inc. announced that its drug REVTORPYK (gedatolisib) is now commercially available in the United States for treatment of hormone receptor-positive, HER2-negative advanced breast cancer patients without PIK3CA mutation, following progression on endocrine therapy. REVTORPYK, a first-in-class inhibitor of all class I PI3K isoforms and mTOR co…
Rank One Computing Corporation (ROC) announced its ROC-003 algorithm secured the top global position for age estimation accuracy across three primary datasets in the National Institute of Standards and Technology (NIST) Face Analysis Technology Evaluation for Age Estimation and Verification (FATE AEV). This achievement solidifies ROC's transition f…
Immutep Limited, a late-stage immunotherapy biotech firm, has received approximately A$856,669 from the Australian Federal Government's R&D tax incentive program for its 2025 fiscal year expenditures. The funding, including additional French and German tax incentives, supports the advancement of its cancer and autoimmune disease therapies, notably …
Eupraxia Pharmaceuticals announced promising 52-week Phase 1b/2a RESOLVE trial results for EP-104GI, showing sustained clinical remission and histologic improvements in patients with Eosinophilic Esophagitis (EoE) after a single dose. The treatment demonstrated favorable safety with no serious adverse events, supporting potential for a once-annual …
Trio Petroleum Corp announced that its Canadian subsidiary acquired 24 oil wells from Marlin Resources in Saskatchewan's Lloydminster region, including 4 producing and 20 shut-in heavy-oil wells. The deal incorporates production of approximately 37 barrels of oil per day with significant upside from a proposed Cummings multilateral well and workove…
Silexion Therapeutics has dosed the first patient in its global Phase 2/3 clinical trial evaluating SIL204, an RNAi therapeutic for KRAS-mutated locally advanced pancreatic cancer. The study combines direct intratumoral and subcutaneous delivery with standard chemotherapy to improve treatment efficacy. The trial initiated at Tel Aviv Sourasky Medic…
AEON Biopharma announced that the FDA's Type 2b meeting provided constructive feedback on the development of ABP-450, its biosimilar to BOTOX®, indicating acceptance of previously completed comparative studies as supportive evidence and endorsing a comparative pharmacodynamic study design. The company plans to submit an IND for the pharmacodynamic …
CTS Corporation has introduced its first Digital Temperature Sensor platform, expanding its portfolio with high-accuracy digital sensing solutions designed for industrial, medical, transportation, and electronics sectors. This new platform offers precise temperature measurement with digital communication capabilities, multiple probe styles, and sim…
NuCana plc announced that the European Patent Office has granted a key composition-of-matter patent for its novel anti-cancer agent NUC-7738, reinforcing its intellectual property protection across major markets. This milestone advances NuCana's long-term commercial strategy and supports ongoing Phase 1/2 clinical trials combining NUC-7738 with pem…
Esperion Therapeutics, wholly owned by ARCHIMED, is rolling out ENBUMYST, an intranasal bumetanide nasal spray for short-term treatment of edema in heart failure patients. This new administration route offers a non-invasive alternative to IV diuretics and aligns with upcoming CMS Ambulatory Specialty Model payment reforms starting 2027. Esperion ai…
Ichor Holdings (ICHR) has retraced roughly 38% from earlier highs and now trades near short-term technical support. Recent beats and guidance show revenue momentum and margin expansion, while valuation metrics look reasonable against revenue growth. This is an actionable short-term trade: enter $59.79, stop $56.00, target $75.00 over the next 10 tr…
MiNK Therapeutics' clinical-stage agenT-797 invariant natural killer T (iNKT) cell therapy platform has been chosen to participate in the ARPA-H funded BioStabilization Systems (BoSS) program aimed at enabling the storage and transportation of living cell therapies at room temperature. This initiative intends to eliminate the reliance on cold-chain…
Booking (BKNG) has been marked down after headlines around Meta's Muse and Expedia's partnership. The pullback leaves the shares trading on a mid-teens P/E with a free cash flow yield near 7.8% and a dividend yield ~1.0% — together implying an approximate 8.8% shareholder yield. That combination of scale, margin profile and capital returns makes a …
Marvell's business is benefiting from AI and optical demand, but the stock now reflects a re-pricing toward nearer-term fundamentals rather than FY2027 optionality. With valuation stretched (market cap ~$231B, P/FCF ~137x) and execution/customer-concentration risks still present, a disciplined mid-term short looks attractive from current levels.
Centerra Gold Inc. plans to release its third quarter 2026 financial and operational results on October 29, 2026, followed by a conference call and webcast on October 30, 2026. The company operates gold and copper mines in Canada and Turkey, and maintains growth projects in North America.
AGM Group Holdings Inc. announced advancements in its AI inference infrastructure strategy, emphasizing the integration of enterprise-grade NAND flash memory and all-flash servers designed for AI applications. The company has started mass production and deliveries of all-flash servers and plans to prioritize customer validation, product adaptation,…
General Motors sits at an inflection where higher-margin defense contracts and software-enabled services can materially improve enterprise profitability while free cash flow and a modest dividend provide shareholder support. This trade idea proposes a controlled long with a clear entry, stop, and target over a 180 trading day horizon to capture re-…
A September poll of 30 economists and analysts raised 2026 oil price forecasts, with Brent expected to average $89.05 a barrel and U.S. crude $83.90, as ongoing disruptions to Gulf exports and the drawdown of Chinese stockpiles keep supply risks at the fore. While slower global growth is seen as capping upside, most forecasters expect inventories t…
